2m 2m 2m 2m 2m 2m 2m
Cullinan Thera (CGEM)
NASDAQ
$21.69+$0.01 (+0.05%)
Price as of Aug 21, 2026 7:30 PM EDT- $1.4BMarket Cap
- 164.71%1-Year Change
- BiotechnologyIndustry
Cullinan Thera (CGEM)
$21.69+$0.01 (+0.05%)
CGEM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.68 | ||
Change | +$0.30 (+1.40%) | ||
Open | $21.72 | ||
High | $22.11 | ||
Low | $21.40 | ||
Previous Close | $21.38 | ||
Volume | 758,223 | ||
30-Day Average Volume | 651,795 | ||
1-Week Change | 6.59% | ||
1-Month Change | 20.04% | ||
1-Year Change | 164.71% | ||
3-Year Change | 105.69% | ||
5-Year Change | -22.96% | ||
Fundamentals | |||
Shares Outstanding | 64.4M | ||
Total Assets | $363.8M | ||
Market Cap | $1.4B | ||
Enterprise Value | $1.3B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$53.7M | ||
Free Cash Flow | -$38.2M | ||
EBIT | -$53.7M | ||
EBITDA | -$53.6M | ||
Net Working Capital | $301.3M | ||
EPS | -$0.81 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -27 | ||
PEG | 3 | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 08/31/2009 | ||
Earnings & Revenue